This review discusses the current understanding of hypertensive retinopathy. It describes the pathomorphology of hypertensive retinopathy according to its grade. The main approaches to classification and elements of pathophysiology are briefly considered, and the clinical significance of hypertensive changes in the fundus is examined. The characteristics of traditional and innovative methods of assessing the retina, and their accuracy in predicting the course of hypertension is discussed. Data from our investigations with scanning laser ophthalmoscopy and optical coherence tomographic angiography are presented. Our data show that uncomplicated hypertension in middle-aged men and women is accompanied by a distinct reduction in the diameter of the retinal arterioles and an expansion of the foveal avascular zone at the level of the superficial capillary plexus of the retina. We review the literature and present the results of our observations, demonstrating the retinoprotective benefits of antihypertensive therapy.
Isolated left ventricular non-compaction (LVNC) is a rare variant of unclassifiable cardiomyopathy (CMP). The basis of the clinical picture of non-compaction CMP is heart failure, arrhythmias, and thromboembolism. Acute cardiac and extracardiac diseases can act as a trigger for the LVNC manifestation. The paper provides an example of diagnosing LVNC in an adult patient after acute myocarditis against the background of vaccination against a new coronavirus infection COVID-19. The characteristics of the ongoing therapy are given and the dynamics of the course of the disease over a period of five months of observation is reflected.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.